Search clinical trials for: robola
Total 2 results
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Harokopio UniversityGraduate Program of the Department of Nutrition and DieteticsUnknown
Sponsors and Collaborators
- Azumio Inc.
- Ondine Biomedical Inc.
- Daqiao Community Health Service Center of Yangpu District
- Spokane Regional Health District
- Robert Pendleton
- Stanford's Innovative Medicines Accelerator
- Genesis Foundation
- National Institute of Drug Abuse
- University Mental Health Research Institute, Athens, Greece
- National Institute of Diabetes and Endocrinology, Egypt
- Montera Health Texas LLC
- Manresana de Micobacteriologia, SL
- Rotem Petranker
- AVAX Technologies
- Prostate Cure Foundation
- Health Factors Inc
- Julie Lefevere
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
- Ancon Technologies Ltd
- Michael Scharl
- View Full List
Medical Conditions
- Age of Probands 18 - 55 Years
- Convalescent Plasma for COVID 19
- Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
- Simulation Training, Laparoscopy
- Desmoid
- Peripheral Artery Calcification
- Ischemic Stroke, Cryptogenic
- Skin Burn Multiple
- Isolation of Enterococci From Samples
- Acute Myocardial Infarction With ST Segment Elevation
- Immunochromatographic
- Vital Signs
- Glanzmann's Thrombasthenia
- Thymoglobulin Dose
- Pain Due to Childhood Vaccination
- Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
- Connective Active Program
- Unwanted Abdomen Fat
- Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
- Universal Adhesive
- View Full List
Drug Interventions
- Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg
- G-CSF
- Administration of etoricoxib
- Golcadomide
- Human menopausal gonadotropin
- Megestrol Acetate 160 MG
- Mild sedation and analgesia
- DKN-01
- GM-CSF
- Glycopyrrolate
- Ciclesonide
- Treament C
- Colchicine group (experimental arm)
- Nab-paclitaxel
- PD-0332991
- Uprifosbuvir
- JNJ 10229570-AAA 3.6% cream
- Bevacizumab
- Single dose of vepdegestrant as tablet formulation (Treatment A)
- Formulation N3
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Belarus
- Contract Research Organizations in Belgium
- Contract Research Organizations in China
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in France
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Hungary
- Contract Research Organizations in Mongolia
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Switzerland
- CRO list by country